Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hematopoietic stem cell transplantation
Phenotype C0039730|thalassemia
Sentences 9
PubMedID- 22645178 Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan.
PubMedID- 20979169 hematopoietic stem cell transplantation for children with thalassemia major in china.
PubMedID- 25017762 Impact of beta-globin mutations on outcome of matched related donor hematopoietic stem cell transplantation for patients with beta-thalassemia major.
PubMedID- 19897573 These results suggest that maternal haploidentical hematopoietic stem cell transplantation is feasible in patients with thalassemia who lack a matched related donor.
PubMedID- 22553502 hematopoietic stem cell transplantation in thalassemia and sickle cell anemia.
PubMedID- 22588927 Objective: to investigate the effects of different doses of antithymocyte globubin-fresenius (atg-f) for allogeneic hematopoietic stem cell transplantation (allo-hsct) in patients with beta-thalassemia major.
PubMedID- 25793043 Objective: thalassemia along with hematopoietic stem cell transplantation (hsct) can lead to major oxidative stress.
PubMedID- 24790059 hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel.
PubMedID- 21239835 This review provides a brief history of hematopoietic stem cell transplantation in thalassemia and reassesses current clinical results with the objective to provide outcome predictions based on modern transplant technologies.

Page: 1